Athanor Capital, LP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Athanor Capital, LP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2021$192,000
-65.8%
19,516
-62.3%
0.00%
-69.2%
Q4 2020$562,000
+172.8%
51,834
+158.6%
0.01%
+62.5%
Q3 2020$206,000
-75.2%
20,046
-49.6%
0.01%
-81.0%
Q2 2020$831,00039,8100.04%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders